Our analyst makes a rational prediction. Stock market however often is irrational. Chip companies, especially revolutionary ones, may at some point be valued much, much higher. I think the holding % (now 40%) and recent upswing in shareprice (X11 in july 2021) in Aehr Test Systems is similar to what probably is going to happen with POET. Both have a small float (<40M). We all know what happens when immense buying begins in companies with a small float. Look at the Aehr chart in july 2021 and the fillings of institutional buying reported in august 2021 (almost 4M shares were bought in just 3 filings just one month after the upswing). fintel.io/so/us/aehr. I believe we’ll all be highly rewarded at the latest when POET starts having + net income OR starts having big sales/revenues. Aehr for example has about 20M yearly revenue/year in the last 5 years. In may 2021 they had + income and the shareprice immediately went through the roof. I don't think it will take that long for POET. POET has a much higher revenue forecast than Aehr. It won't take years before Vanguard decides to buy 2M POET shares and we go to 50usd/share. I believe our small float leads to low liquidity, for now, but on a given moment, that will definitely change and tutes will crawl over each other to buy shares.